Jason Pharmaceuticals, Inc. 401(k) Review & Grade
Medifast, Inc. 401(k) Plan
Baltimore, MDManufacturing610 active participantsPlan year 2024
Estimate from the plan's Form 5500 filing · How we grade
$3,289Employer $ per active participant
$7,337Employee $ saved per active participant
0.19%Direct admin cost, % of plan assets
$41.8MNet plan assets, end of year
$55,327Average balance per account
Score breakdown
- Employer generosity33.4 / 5067th percentile for employer $ per participant
- Low cost13.8 / 2555th percentile for low admin cost vs. same-size plans
- Employee saving11.4 / 1576th percentile for employee $ per participant
- Plan features3 / 10Default investment
Total score62 / 100 · Grade B
This plan vs. peers
Peers: Manufacturing plans with 500–2,499 active participants (2,376 plans).
| Measure | Percentile |
|---|---|
| Employer $ per participant | 67th |
| Lower admin cost | 55th |
| Employee saving | 76th |
| Peers that auto-enroll | 59% |
Get the monthly 401(k) report card
The best and worst plans, new grades as filings post. One email a month, no spam.
Red flags from the filing
No red flags were reported on this filing's compliance questions.
What to do if you're in this plan
- Jason Pharmaceuticals put in about $3,289 per active participant, more than the typical peer ($2,320). Contribute at least enough to collect the full match. Skipping it leaves part of your pay on the table.
- The filing shows total dollars, not the match formula. Ask HR for the Summary Plan Description so you know the exact match and vesting schedule.
- Fund expense ratios aren't in the filing. Look them up in your 404(a)(5) fee disclosure and favor low-cost index or target-date funds.
- Changing jobs? You can usually leave the money in the plan, move it to your new employer's plan, or roll it into an IRA. Don't cash out: you'd owe taxes and possibly a 10% penalty.
The raw numbers from the filing
| Employer contributions | $2,004,348 |
| Participant (employee) contributions | $4,472,097 |
| Other contributions (incl. rollovers in) | $535,890 |
| Administrative expenses paid from the plan | $73,355 |
| Benefits paid out | $4,373,826 |
| Net assets, start / end of year | $34.1M / $41.8M |
| Active participants, start / end of year | 631 / 588 |
| Participants with account balances | 756 |
| Auto-enrollment (feature code 2S) | Not reported |
| Auditor | Coker and Company, LLC |
Largest service providers (Schedule C)
| Fidelity Investments Institutional | $73,355 reported compensation |
Source: DOL EFAST2 Form 5500 filing, acknowledgment ID 20250729094612NAL0001217411001, received 2025-07-29, EIN 52-1237423, plan #003, plan year 2024-01-01 to 2024-12-31. Verify at efast.dol.gov.